Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers